Literature DB >> 14683591

Optimization of electroporation parameters for the intramuscular delivery of plasmids in pigs.

Amir S Khan1, Louis C Smith, Ronald V Abruzzese, Kathleen K Cummings, Melissa A Pope, Patricia A Brown, Ruxandra Draghia-Akli.   

Abstract

Increased transgene expression after plasmid transfer to the skeletal muscle is obtained with electroporation in many species, but optimum conditions are not well defined. Using a plasmid with a muscle-specific secreted embryonic alkaline phosphatase (SEAP) gene, we have optimized the electroporation conditions in a large mammal (pig). Parameters tested included electric field intensity, number of pulses, lag time between plasmid injection and electroporation, and plasmid delivery volume. Electric pulses, between 0.4 and 0.6 Amp constant current, applied 80 sec after the injection of 0.5 mg SEAP-expressing plasmid in a total volume of 2 mL produced the highest levels of expression. Further testing demonstrated that electroporation of a nondelineated injection site reduces the levels of SEAP expression. These results demonstrate that electroporation parameters such as amperage, lag time, and the number of pulses are able to regulate the levels of reporter gene expression in pigs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14683591     DOI: 10.1089/104454903322625019

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  11 in total

1.  Intradermal DNA vaccination enhanced by low-current electroporation improves antigen expression and induces robust cellular and humoral immune responses.

Authors:  Natalie A Hutnick; Devin J F Myles; Bernadette Ferraro; Colleen Lucke; Feng Lin; Jian Yan; Kate E Broderick; Amir S Khan; Niranjian Y Sardesai; David B Weiner
Journal:  Hum Gene Ther       Date:  2012-08-02       Impact factor: 5.695

Review 2.  What you always needed to know about electroporation based DNA vaccines.

Authors:  Anita Gothelf; Julie Gehl
Journal:  Hum Vaccin Immunother       Date:  2012-10-30       Impact factor: 3.452

3.  Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination.

Authors:  P Fagone; D J Shedlock; H Bao; O U Kawalekar; J Yan; D Gupta; M P Morrow; A Patel; G P Kobinger; K Muthumani; D B Weiner
Journal:  Gene Ther       Date:  2011-05-05       Impact factor: 5.250

4.  Numerical optimization of gene electrotransfer into muscle tissue.

Authors:  Anze Zupanic; Selma Corovic; Damijan Miklavcic; Mojca Pavlin
Journal:  Biomed Eng Online       Date:  2010-11-04       Impact factor: 2.819

Review 5.  Plasmid IL-12 electroporation in melanoma.

Authors:  Edward Cha; Adil Daud
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

6.  Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo.

Authors:  Kimberly A Kraynyak; Michele A Kutzler; Neil J Cisper; Dominick J Laddy; Matthew P Morrow; Thomas A Waldmann; David B Weiner
Journal:  Hum Gene Ther       Date:  2009-10       Impact factor: 5.695

7.  Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus.

Authors:  Karuppiah Muthumani; Katthikbabu M Lankaraman; Dominick J Laddy; Senthil G Sundaram; Christopher W Chung; Eric Sako; Ling Wu; Amir Khan; Niranjan Sardesai; Joseph J Kim; Paluru Vijayachari; David B Weiner
Journal:  Vaccine       Date:  2008-04-14       Impact factor: 3.641

8.  A comparison of the growth responses following intramuscular GHRH plasmid administration versus daily growth hormone injections in young pigs.

Authors:  Amir S Khan; Ruxandra Draghia-Akli; Roman J Shypailo; Kenneth I Ellis; Harry Mersmann; Marta L Fiorotto
Journal:  Mol Ther       Date:  2009-10-06       Impact factor: 11.454

Review 9.  Electroporation advances in large animals.

Authors:  Scott D Reed; Shulin Li
Journal:  Curr Gene Ther       Date:  2009-08       Impact factor: 4.391

10.  Gene therapy by electroporation for the treatment of chronic renal failure in companion animals.

Authors:  Patricia A Brown; Angela M Bodles-Brakhop; Melissa A Pope; Ruxandra Draghia-Akli
Journal:  BMC Biotechnol       Date:  2009-01-16       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.